India to Ukraine: Trastuzumab Export Trade Route

The India to Ukraine Trastuzumab corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $4.3M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 94% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $429.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with trastuzumab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 11.9%, placing it at rank #8 among India's top trastuzumab export destinations globally.

On the import side, key buyers of Indian trastuzumab in Ukraine include PII OST-WEST EXPRESS, PII OST-WEST EXPRESS . PII OST-WEST EXPRESS is the single largest importer with 9 shipments valued at $4.0M USD.

India's trastuzumab exports to Ukraine are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Ukraine benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $429.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ogivri-150 trastuzumab lyophilized powder for injection (rdna origin) 150 mg batch no:7802392,7802396,7802397,7802416 and ogivri-150 trastuzumab lyophilized powde, suggesting that buyers in Ukraine tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PII OST-WEST EXPRESS is the largest importer with 9 shipments worth $4.0M USD — representing 94% of all trastuzumab imports from India on this route.